Fuchs CS - Search Results

1

Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study.

Fuchs CS, Marshall J, Mitchell E, Wierzbicki R, Ganju V, Jeffery M, Schulz J, Richards D, Soufi-Mahjoubi R, Wang B, Barrueco J. Fuchs CS, et al. J Clin Oncol. 2007 Oct 20;25(30):4779-86. doi: 10.1200/JCO.2007.11.3357. J Clin Oncol. 2007. PMID: 17947725 Clinical Trial.

2

Adjuvant chemotherapy for colon and rectal cancer.

Fuchs CS, Mayer RJ. Fuchs CS, et al. Semin Oncol. 1995 Oct;22(5):472-87. Semin Oncol. 1995. PMID: 7570058 Review. No abstract available.

3

A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors.

Ryan DP, Lynch TJ, Grossbard ML, Seiden MV, Fuchs CS, Grenon N, Baccala P, Berg D, Finkelstein D, Mayer RJ, Clark JW. Ryan DP, et al. Among authors: fuchs cs. Cancer. 2000 Jan 1;88(1):180-5. doi: 10.1002/(sici)1097-0142(20000101)88:1<180::aid-cncr25>3.3.co;2-h. Cancer. 2000. PMID: 10618622 Clinical Trial.

4

A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma.

Ryan DP, Kulke MH, Fuchs CS, Grossbard ML, Grossman SR, Morgan JA, Earle CC, Shivdasani R, Kim H, Mayer RJ, Clark JW. Ryan DP, et al. Among authors: fuchs cs. Cancer. 2002 Jan 1;94(1):97-103. doi: 10.1002/cncr.10202. Cancer. 2002. PMID: 11815964 Free article. Clinical Trial.

5

Chemotherapy options for gastric cancer.

Meyerhardt JA, Fuchs CS. Meyerhardt JA, et al. Among authors: fuchs cs. Semin Radiat Oncol. 2002 Apr;12(2):176-86. doi: 10.1053/srao.2002.30823. Semin Radiat Oncol. 2002. PMID: 11979419 Review.

6

A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma.

Fuchs CS, Clark JW, Ryan DP, Kulke MH, Kim H, Earle CC, Vincitore M, Mayer RJ, Stuart KE. Fuchs CS, et al. Cancer. 2002 Jun 15;94(12):3186-91. doi: 10.1002/cncr.10607. Cancer. 2002. PMID: 12115351 Free article.

7

Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer.

McCollum AD, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB 3rd, Fuchs CS. McCollum AD, et al. Among authors: fuchs cs. J Natl Cancer Inst. 2002 Aug 7;94(15):1160-7. doi: 10.1093/jnci/94.15.1160. J Natl Cancer Inst. 2002. PMID: 12165641 Clinical Trial.

8

A phase II study of troglitazone, an activator of the PPARgamma receptor, in patients with chemotherapy-resistant metastatic colorectal cancer.

Kulke MH, Demetri GD, Sharpless NE, Ryan DP, Shivdasani R, Clark JS, Spiegelman BM, Kim H, Mayer RJ, Fuchs CS. Kulke MH, et al. Among authors: fuchs cs. Cancer J. 2002 Sep-Oct;8(5):395-9. doi: 10.1097/00130404-200209000-00010. Cancer J. 2002. PMID: 12416897 Clinical Trial.

9

Impact of diabetes mellitus on outcomes in patients with colon cancer.

Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB 3rd, Fuchs CS. Meyerhardt JA, et al. Among authors: fuchs cs. J Clin Oncol. 2003 Feb 1;21(3):433-40. doi: 10.1200/JCO.2003.07.125. J Clin Oncol. 2003. PMID: 12560431 Clinical Trial.

10

Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer.

Fuchs CS, Moore MR, Harker G, Villa L, Rinaldi D, Hecht JR. Fuchs CS, et al. J Clin Oncol. 2003 Mar 1;21(5):807-14. doi: 10.1200/JCO.2003.08.058. J Clin Oncol. 2003. PMID: 12610178 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

748 results

Search Page